News

Flagstar Financial, Inc. Announces Cash Dividends for 2025

Flagstar Financial, Inc. Announces Cash Dividends for 2025

Flagstar Financial, Inc. Declares Quarterly Cash Dividends

Flagstar Financial, Inc. (NYSE: FLG), a prominent player in the banking sector, has made an exciting announcement regarding its quarterly cash dividends. This decision reflects the Company's commitment to delivering value to its shareholders. The Board of Directors has declared a quarterly cash dividend of $0.01 per share on the common stock of the Company. This dividend is to be paid on March 17, 2025, to shareholders recorded as of March 7, 2025.

Details on Preferred Stock Dividends

In addition to the common stock dividends, the Board has also declared cash dividends on two series of preferred stocks. The Fixed-to-Floating Rate Noncumulative Perpetual Preferred Stock, Series A, will have a dividend rate of $15.94 per preferred share, translating to $0.3984 for each depositary share. Holders of this preferred stock will also receive dividends on March 17, 2025, with a record date of March 7, 2025.

Series B Noncumulative Convertible Preferred Stock

The Series B Noncumulative Convertible Preferred Stock is set to offer dividends of $3.3333 per share, also payable on March 17, 2025, to those on record as of March 7, 2025. This organized approach to asset distribution showcases the transparency and responsibility in managing shareholder interests.

Dividend on Series D Non-Voting Common Equivalent Stock

Moreover, Flagstar will dispense a similar dividend of $3.3333 per share on its Series D Non-Voting Common Equivalent Stock, also payable on March 17, 2025. This commitment further emphasizes the Company’s aim to maintain an attractive return for its investors.

About Flagstar Financial, Inc.

Flagstar Financial, Inc. serves as the parent entity of Flagstar Bank, N.A., recognized as one of the largest regional banks in the United States. The Company prides itself on its extensive offerings and robust operational footprint. Headquartered in Hicksville, New York, as of the end of the previous year, Flagstar reported remarkable assets totaling approximately $100.2 billion, with loans amounting to $69.2 billion. The deposit base was at $75.9 billion, reflecting a solid financial foundation, along with total equity reaching $8.2 billion.

Branch Network and Services

The extensive network of Flagstar Bank includes 418 branches, primarily located in the Northeast and Midwest, with a growing presence in the Southeast and West Coast. Additionally, the Bank boasts around 80 private banking teams spread across more than 10 cities near New York City and the West Coast, catering to the unique requirements of high-net-worth individuals and their enterprises.

Investor and Media Relations

For inquiries regarding investments or media relations, interested parties can reach out to Salvatore J. DiMartino at (516) 683-4286 for investor inquiries and to Steven Bodakowski at (248) 312-5872 for media inquiries. Both contacts are approachable and ready to assist with relevant questions concerning the Company’s operations and future directions.

Frequently Asked Questions

What is the cash dividend announced by Flagstar Financial, Inc.?

Flagstar Financial, Inc. has declared a cash dividend of $0.01 per share on its common stock, payable on March 17, 2025.

When will the dividends for preferred stocks be paid?

The preferred stock dividends will also be paid on March 17, 2025, with the record date set for March 7, 2025.

How does Flagstar Financial, Inc. support its shareholders?

By declaring consistent cash dividends, Flagstar shows its commitment to providing value to its shareholders and demonstrating financial stability.

What are the recent financial highlights of Flagstar Financial, Inc.?

As of late last year, Flagstar reported approximately $100.2 billion in assets and $75.9 billion in deposits, indicating a strong financial position.

Who can I contact for more information about Flagstar Financial?

For more information, you can contact Salvatore J. DiMartino for investor inquiries or Steven Bodakowski for media inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Halozyme Therapeutics Boosts Revenue Guidance, Analysts React

Updated Category News Views 33

Halozyme Therapeutics' Earnings Performance Insights Recently, analysts adjusted their outlook for Halozyme Therapeutics (NASDAQ: HALO), following a robust earnings report for the third quarter of 2024. Piper Sandler increased its price target to $52 from $51, while maintaining a Neutral rating on the stock. This adjustment came in light of Halozyme's impressive...

Continue Reading
DarioHealth's Innovative Digital Health Platform Cuts Costs

Updated Category News Views 154

DarioHealth Announces Major Findings in Cost Reduction Recently, DarioHealth Corp. (NASDAQ: DRIO), a frontrunner in digital health solutions, revealed significant findings regarding the cost reductions associated with its innovative digital health platform. This research, presented at a prominent health economics and outcomes conference, highlights the company's...

Continue Reading
Antibody Drug Conjugates Market Insights and Growth Forecast

Updated Category News Views 67

Overview of the Antibody Drug Conjugates Market The Global Antibody Drug Conjugates (ADCs) Market is experiencing impressive growth, with projections indicating an increase from USD 13.7 billion in 2024 to a remarkable USD 51.2 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 15.8%. The rise is primarily driven by the increasing prevalence...

Continue Reading
Haut.AI Enhances Neutrogena Skin360 with Innovative AI Tech

Updated Category News Views 296

Reimagining the Neutrogena Skin360 Experience Haut.AI is thrilled to reveal its collaboration with Neutrogena to revamp the renowned Skin360 experience. This refresh integrates Haut.AI's state-of-the-art AI skin analysis technology, allowing for hyper-personalized skincare recommendations tailored to each user's unique skin needs. This innovative approach utilizes...

Continue Reading
Associates in Gastroenterology: A Leader in Patient-Centered Care

Updated Category News Views 71

Associates in Gastroenterology: A Leader in Patient-Centered Care Associates in Gastroenterology (AiG) is a prominent gastroenterology practice dedicated to delivering outstanding patient care. Located in Nashville, AiG prioritizes comprehensive digestive health services that respond to the diverse needs of the local community. Commitment to Exceptional Care Dr. Kevin...

Continue Reading